electroCore to Present at the HC Wainwright Virtual 22nd Annual Global Investment Conference

Rhea-AI Summary

electroCore, Inc. (Nasdaq: ECOR) announced its participation in the HC Wainwright Virtual 22nd Annual Global Investment Conference from September 14-16, 2020. The company will present on September 16, 2020, from 1:30-1:50 PM EDT. Interested parties can access a live webcast through the Investors section of the company's website. electroCore specializes in bioelectronic medicine, focusing on non-invasive vagus nerve stimulation therapy for conditions such as cluster headaches and migraines.

BASKING RIDGE, N.J., Sept. 11, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that management is scheduled to present at the HC Wainwright Virtual 22nd Annual Global Investment Conference, which is being held from September 14-16, 2020.

Presentation details:

Date: Wednesday, September 16, 2020
Time: 1:30-1:50pm EDT

A live webcast of the presentation will be available on the Investors section of the company's website: www.electrocore.com

About electroCore, Inc.

electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The company’s current indications are the preventative treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache.

For more information, visit: www.electrocore.com

Investors:
Hans Vitzthum
LifeSci Advisors
617-430-7578
hans@lifesciadvisors.com

or

Media Contact:
Jackie Dorsky
electroCore
973-290-0097

FAQ

What is the date and time of electroCore's presentation at the HC Wainwright Global Investment Conference 2020?

electroCore will present on September 16, 2020, from 1:30 PM to 1:50 PM EDT.

Where can I watch the electroCore presentation live?

The live webcast of the electroCore presentation will be available on the Investors section of the company's website.

What company is presenting at the HC Wainwright Virtual 22nd Annual Global Investment Conference?

electroCore, Inc. (Nasdaq: ECOR) is presenting at the conference.

What conditions does electroCore's therapy target?

The therapy targets the preventative treatment of cluster headaches and migraines, as well as the acute treatment of migraines and episodic cluster headaches.